Month: <span>September 2025</span>
Month: September 2025

Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Catalonia, Spain

Eur J Pediatr. 2025 Sep 13;184(10):616. doi: 10.1007/s00431-025-06440-x. ABSTRACT To analyse the effect of nirsevimab immunoprophylaxis on RSV-associated outcomes after two consecutive epidemic seasons in …

The novel CFAbd-Score.kidâ’¸ reveals a significant decline of abdominal symptoms in children with Cystic fibrosis aged 6 through 11 years on Elexacaftor/Tezacaftor/Ivacaftor – first results

J Cyst Fibros. 2025 Sep 12:S1569-1993(25)01582-6. doi: 10.1016/j.jcf.2025.09.003. Online ahead of print. ABSTRACT BACKGROUND: Recently, elexacaftor/tezacaftor/ivacaftor (ETI), the turning point in the course of Cystic …